Combining 5-ALA-PDT with berbamine as an in vitro multimodal therapy approach against bladder cancer cells.

Sci Rep · 2026 · PMC13046741 · PMID 41922474

Europe PMC DOI

hedged sentence

0.0001

closest p · 0.0× alpha

0.0001

boldest claim

The sentences

highly significantp < 0.0001actually significant

Irradiated samples treated with 5-ALA of 50 or 100 μg/ml showed highly significant ( p < 0.0001) reductions in cell viability compared to the irradiated 5-ALA-free controls, decreasing progressively with increasing light doses from 0 to 32 J/cm 2 .

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.